FULLER H B CO (FUL) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds adding versus the previous quarter. Insiders were net buyers over the last 90 days ($1.1M bought vs $60.5K sold). Latest close $48.16 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 11, 2026 · Congress to Nov 16, 2026.
Mairs & Power Funds · First Eagle Investment Management — 2 tracked funds hold FUL. See all holders.
Insiders bought on the open market (11 purchases, $1.1M) vs 1 sale ($60.5K). Latest buy: Oct 16, 2026. Insider trading
Merck & Co., Inc. (MRK) · LINDE PLC (LIN) · ELI LILLY & Co (LLY) · PROCTER & GAMBLE Co (PG) · PFIZER INC (PFE) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Mairs & Power Funds | 1.30% | 2,435,168 | ADDED (+3.1%) Q3 filed Nov 16 |
| First Eagle Investment Management | 0.03% | 339,343 | ADDED (+48.5%) Q3 filed Nov 10 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -16.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 348 of 8,857 filers |
| Long-only filers among them | 348 |
| Change vs 2026 Q1 | +19 net · 336 entered · 317 exited |
| Shares reported, all filers | 55,728,694 |
| Reported value, all filers | $3.1B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Adhesives & Sealants (SIC 2891) |
| Revenue · FY2025 | $3.5B |
| Net income · FY2025 | $152.0M |
| Total assets · FY2025 | $5.2B |
| Shares outstanding | 53,829,119 |
| Market cap (at latest close) | $2.6B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Sep 18, 2026.
| Shares short · Oct 15, 2026 | 2,365,737 |
| Share of shares outstanding | 4.39% |
| Days to cover | 2.96 |
Shares short at recent settlements — Jul 31, 2026: 2.8M · Aug 14, 2026: 2.9M · Aug 31, 2026: 3.0M · Sep 15, 2026: 2.9M · Sep 30, 2026: 2.9M · Oct 15, 2026: 2.4M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Sep 18, 2026.
| Shares failed to deliver · Oct 14, 2026 | 177 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | <0.1% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 266 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 177.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Sep 18, 2026.
9 insiders bought on the open market in the last 90 days (11 purchases, $1.1M), against 1 sale by 1 insider ($60.5K). Latest buy: Oct 16, 2026.
Source: SEC Form 4 filings. Open-market transactions only.
| Latest open-market buy | Transaction price | Price change since disclosure |
|---|---|---|
| Malik Muhammad Shahbaz · 478.6594 shares on Oct 16, 2026 · filed Oct 19, 2026 | $52.23 | -5.5% (close Oct 20, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Oct 20, 2026). The transaction price is what the insider paid; the price change is on closing prices (dividends excluded).
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Weaver Nathan D. | Exec VP, Business Transform. | Sell | 1,200 | $50.42 | $60.5K | SEC filing |
| Oct 16, 2026 | Malik Muhammad Shahbaz | Senior VP, BAS | Buy | 478.6594 | $52.23 | $25.0K | SEC filing |
| Oct 7, 2026 | BAILLY R JEFFREY | Buy | 10,000 | $50.00 | $500.0K | SEC filing | |
| Sep 30, 2026 | Martin Celine Christine | Buy | 464.599 | $49.50 | $23.0K | SEC filing | |
| Sep 29, 2026 | Happe Michael J | Buy | 2,000 | $49.62 | $99.2K | SEC filing | |
| Sep 29, 2026 | Lauber Charles T | Buy | 2,005 | $49.87 | $100.0K | SEC filing | |
| Sep 29, 2026 | Zaheer Srilata | Buy | 40 | $49.97 | $2.0K | SEC filing | |
| Sep 28, 2026 | FLORNESS DANIEL L | Buy | 2,030 | $49.34 | $100.2K | SEC filing | |
| Sep 28, 2026 | HANDLEY THOMAS W | Buy | 2,000 | $49.41 | $98.8K | SEC filing | |
| Sep 28, 2026 | Rasmussen Trangsrud Teresa J | Buy | 1,542 | $48.96 | $75.5K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Weaver Nathan D. | Officer | 9,561 | $593.3K | Aug 11, 2026 | SEC filing |
| Nov 13, 2025 | Weaver Nathan D. | Officer | 7,075 | $413.0K | Nov 13, 2025 | SEC filing |
| Oct 27, 2025 | Corkrean John J | Officer | 14,222 | $857.8K | Oct 27, 2025 | SEC filing |
| Aug 8, 2025 | Magalhaes Joao | Officer | 1,099 | $61.9K | Aug 8, 2025 | SEC filing |
| Aug 7, 2025 | Magalhaes Joao | Officer | 1,046 | $58.8K | Aug 7, 2025 | SEC filing |
| Jul 10, 2025 | Martsching Robert J | Officer | 9,546 | $613.9K | Jul 10, 2025 | SEC filing |
| Jan 28, 2025 | Du Xinyu | Officer | 69 | $4.4K | Jan 28, 2025 | SEC filing |
| Jan 27, 2025 | Du Xinyu | Officer | 240 | $15.3K | Jan 27, 2025 | SEC filing |
| Jul 12, 2024 | Martsching Robert J | Officer | 7,292 | $590.3K | Jul 12, 2024 | SEC filing |
| Jul 12, 2024 | Campe Heather | Officer | 23,696 | $2.0M | Jul 12, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Dimensional Fund Advisors LP | SC 13G | 2,857,738 | 5.3% | Jun 30, 2026 | SEC filing |
| Apr 30, 2026 | Vanguard Capital Management | SC 13G | 2,847,123 | 5.2% | Mar 31, 2026 | SEC filing |
| Apr 29, 2026 | Vanguard Portfolio Management | SC 13G | 3,769,235 | 6.9% | Mar 31, 2026 | SEC filing |
| Mar 27, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Oct 17, 2025 | BlackRock, Inc. | SC 13G/A | 7,776,207 | 14.4% | Sep 30, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Adhesives & Sealants (SIC 2891). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Insiders
· Insider Cluster Buying — Last 90 days: 3 or more different insiders bought on the open market
· Insider Net Buying — Last 90 days: more insider buy transactions than sell transactions
· Opportunistic Buys (Non-Routine) — Last 90 days: 2 or more insiders with no routine buying pattern bought on the open market
Financial Screens
· Graham — Sound finances and a long run of profits
· Dividend Growth — Dividends raised for more than 10 years
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
· Shareholder Yield — Cash returned through dividends and buybacks
· Earnings Stability — Small earnings swings and almost no loss years
Key figures
· Graham — Current ratio: 1.70 · Straight profitable years: 18 · Debt ratio: 1.59 · Latest net income: $152.0M
· Dividend Growth — Dividend per share: 0.93 · Dividend yield: 1.9% · Straight dividend years: 18 · 10-yr dividend growth: 68.7%
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 2.22 · Operating cash flow: $263.5M · Net income: $152.0M
· Shareholder Yield — Shareholder yield: 4.0% · of which dividends: 1.8% · of which buybacks: 2.2%
· Earnings Stability — Earnings variation (CV): 0.23 · Loss years (of 10): 0 · Latest net income: $152.0M
· Insider Cluster Buying — Insiders buying: 9 · Buy txns: 11 · Buy value: $1.1M · Latest buy: Oct 16, 2026
· Insider Net Buying — Buy txns: 11 · Sell txns: 1 · Buy value: $1.1M · Latest buy: Oct 16, 2026
· Opportunistic Buys (Non-Routine) — Opportunistic buyers: 7 · Buy txns: 9 · Buy value: $621.3K · Latest buy: Sep 30, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
Also held by the tracked funds that hold FUL — ranked by lift, the co-holding pattern described in Methodology: Merck & Co., Inc. (MRK) · LINDE PLC (LIN) · ELI LILLY & Co (LLY) · PROCTER & GAMBLE Co (PG) · PFIZER INC (PFE) · AbbVie Inc. (ABBV) · BRISTOL MYERS SQUIBB CO (BMY) · COLGATE PALMOLIVE CO (CL).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Nov 16, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers | SEC filing |
| Oct 22, 2026 | 1.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 19, 2026 | 8.01 Other Events · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Merck & Co., Inc. (MRK) · Track Record: how the signals scored · Practice timing on FUL
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.